含有血小板丰富的等离子体嵌入的多孔聚烯酸薄膜具有较大的表面积,可有效实现血液静止
Min Ji Kim1, Ye Jin Song1, Tae Gyun Kwon2
1Department of Nanobiomedical Science, Dankook University, Cheonan, 31116, Republic of Korea.
Tissue engineering and regenerative medicine
|June 19, 2024
概括
这项研究从过期的PRP开发了一种新的丰富血小板血 (PRP) 嵌入的多孔膜 (PRP-FLSS). 这种先进的止血剂显著加速血液凝固,为治疗严重出血提供了有前途的解决方案.
科学领域:
- 生物材料科学 生物材料科学
- 血液静止研究 血液静止研究
- 再生医学是一种再生医学.
背景情况:
- 失控出血带来严重的死亡风险,需要有效的止血剂.
- 有添加剂的聚合物生物材料在临床上用于加速血液凝固.
- 富含血小板血 (PRP) 是一种强大的静血添加剂,由于其丰富的凝固因子.
研究的目的:
- 开发和评估一种使用废弃的富血小板血 (PRP) 的新型血液静止剂.
- 为了创建一个PRP嵌入的多孔膜与叶子堆叠结构 (FLSS) 快速静血.
主要方法:
- 使用加热冷却技术制造具有树叶堆叠结构 (LSS) 的聚烯 (PCL) 薄膜.
- 通过冷解周期激活过期的PRP以释放凝固因子.
- 将激活的PRP嵌入PCL-LSS膜中,以产生PRP-FLSS血静剂.
主要成果:
- 在体外和体外研究中,PRP-FLSS已经证明了生物相容性.
- 该药物在小鼠肝脏出血模型中显著加速了血液凝结.
- 快速出血的预防归因于激活PRP和LSS结构的协同作用.
结论:
- PRP-FLSS显示出作为一种先进的静血剂的潜力.
- 该研究强调了生物功能资源的上循环平台,减少了浪费.
- 这种方法为开发有效的静血材料提供了一种可持续的方法.
相关概念视频
Formation of the Platelet Plug
5.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.8K
Introduction to Hemostasis
7.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675


